max-40279-01
Showing 1 - 4 of 4
Solid Tumor Trial in Hangzhou (MAX-40279-01)
Recruiting
- Solid Tumor
- MAX-40279-01
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University
Jan 18, 2022
Metastatic Colorectal Cancer Trial in Guangzhou (MAX-40279-01, regorafenib)
Not yet recruiting
- Metastatic Colorectal Cancer
- MAX-40279-01
- regorafenib
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Nov 22, 2021
AML Trial in Hangzhou (MAX-40279-01)
Recruiting
- AML
- MAX-40279-01
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University
Jan 18, 2022
Leukemia, Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia Trial in Tianjin (MAX-40279-01)
Recruiting
- Leukemia
- +3 more
- MAX-40279-01
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Sep 29, 2021